Logo

Illumina Raises $28M Private Equity Financing

Jan 16, 2000
Premium

S

AN DIEGO--Illumina, a two-year-old company that develops single-nucleotide polymorphism analysis technologies, completed a $28 million private equity financing round last week. New investors included the Tisch Family Fund, Lombard Odier & Cie, State Farm Automobile Insurance, Chase Capital Partners, PE, Dow Chemical, and Chevron Technology Ventures. Existing investors--Venrock Associates, Arch Venture Partners, CW Group, and Tredegar Investments--also participated.

Filed under

Informatics
Breaking News
The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.